Melatonin

BMJ

Volumn 312, Issue 7041, 1996, Pages 1242-1243

  Arendt, J ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; LOW DOSE ORAL CONTRACEPTIVE; MELATONIN;

AGING; BLEEDING; CIRCADIAN RHYTHM; DRUG ACTIVITY; DRUG SAFETY; EDITORIAL; HEADACHE; HUMAN; MASS MEDIUM; PINEAL BODY; PRIORITY JOURNAL; SLEEP DISORDER; SLEEP WAKING CYCLE;

AGING; CIRCADIAN RHYTHM; HUMANS; MELATONIN; SLEEP; SLEEP DISORDERS;

EID: 0029979582     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7041.1242     Document Type: Editorial

References (19)

1. Pierpaoli W, Regelson W. The melatonin miracle. New York: Simon and Schuster, 1995.
2. Reiter RJ, Robinson J. Melatonin. New York: Bantam Books, 1995.
3. Arendt J. Melatonin and the mammalian pineal gland. London: Chapman Hal1, 1994.
4. Vollrath L, Semm P, Gammel G. Sleep induction by intranasal application of melatonin. Adv Biosci 1981; 29: 327–329.
5. Dollins AB, Zhdanova IV, Wurtman PJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature and performance. Proc Natl Acad Sci USA 1994; 91: 1824–8.
6. Deacon S, Arendt J. Melatonin-induced temperature suppression and its acute pase-shifting effects correlate in a dose-dependent manner in humans. Brain Res 1995; 688: 77–85.
7. Lewy AJ, Saeeduddin A, Latham-Jackson JM, Sack R. Melatonin shifts human circadian rhythms according to a phase response curve. Chronobiol Internal 1992; 9: 380–392.
8. Arendt J, Aldhous M, Wright. J. Synchronisation of a disturbed sleep-wake cycle in a blind man by rnelatonin treatment. Lancet 1988; 1: 772–773.
9. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Schlitner A. Sleep disorders and melatonin rhythms in elderly people. BMJ 1994; 309: 167.
10. Arendt J, Deacon S, English J, Hampton S, Morgan L. Melatonin and adjustment to phase shift. Work hours, sleepiness and accidents. Proceedings of the International workshop, Karo-linska Institute, Stockholm, September 1994. J Sleep Res 1995: 4(suppl 2):74–9.
11. Haimov I, Lavie P, Laudon M, Herer P, Vigdor C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep 1995; 18: 598.
12. Maestroni G, Conti A. The pineal immuno-opioid network: mechanisms and significance. Ann New York Acad Sci 1992; 650: 56–59.
13. Lewinski A, Zelazowski P, Sewcrynek E, Zerek-Melen G, Szkudlinski M, Zelazowska E. Melatonin induced suppression of human lymphocyte natural killer cell activity in vitro. J Pineal Res 1989; 7: 153–164.
14. Wiechmann AF, O'Steen WK. Melatonin increases photoreceptor susceptibility to light-induced damage. Invest Ophthalmol Vis Sci 1992; 33: 1894–1902.
15. Wilson S, Blask D, Lemus-Wilson A. Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro. J Clin Endocrinol Metab 1992; 75: 669–670.
16. Stanberry R, Das Gupta TK, Beattie CW. Photoperiodic control of melanoma growth in hamsters: influence of pinealectomy and melatonin. Endocrinology 1983; 113: 469–475.
17. Cohen M, Josimovich J, Brzezinski A. Melatonin: from contraception to breast cancer prevention. Potomac, USA: Sheba Press Ltd, 1995.
18. Reppert SM, Weaver DR. Melatonin madness. Cell 1995; 83: 1059–62.
19. Sugden D. Psychopharmacological effects of melatonin in mouse and rat. Pharmacol Exper Therap 1983; 227: 587–591.